Sun Pharmaceutical Industries Ltd.: A Quarter of All-Around Strong Growth Sales up 66%, Profit up 121%

28th July 2008 MUMBAI, India, July 28 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) reported a quarter of strong growth for the first quarter ending June 30, 2008. There is significant one-time sales and profit component in these financials linked to the sales of products that enjoy limited duration marketing exclusivity in the US. Highlights of Q1FY09 consolidated financials more

Shire plc: IFRS Results for the Year Ending December 31, 2007

25th March 2008 BASINGSTOKE, England, March 25 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces its preliminary results prepared under International Financial Reporting Standards ("IFRS") for the twelve months to December 31, 2007. On February 21, 2008 Shire announced its results for the same period under US GAAP. more

2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer

4th February 2008 DÃœSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just completed another record year. In 2007 the company achieved sales of EUR957.7m, up by 48.1%; the adjusted Group EBITDA margin reached 19%. "This gratifying development completely and fully confirms our strategy," says Dr. Axel Herberg, Chief Executive Officer of Gerresheimer AG: "With the help of acquisitions we have successfully expanded our global presence and set the course for further... more

Most viewed

Shire plc: IFRS Results for the Year Ending December 31, 2007

2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer

2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer

Sun Pharmaceutical Industries Ltd.: A Quarter of All-Around Strong Growth Sales up 66%, Profit up 121%